Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C. (4th July 2022)
- Record Type:
- Journal Article
- Title:
- Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C. (4th July 2022)
- Main Title:
- Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C
- Authors:
- Andraka-Christou, Barbara
Saloner, Brendan
Gordon, Adam J.
Totaram, Rachel
Randall-Kosich, Olivia
Golan, Matthew
Stein, Bradley D. - Abstract:
- ABSTRACT: Background: Medications for opioid use disorder (MOUDs) are the gold standard for OUD treatment but are underused. To our knowledge, no published study has systematically identified and categorized state policy innovations for expanding MOUD utilization. Objective: We sought to identify and categorize state MOUD policy innovations. Methods: Within a stratified random sample of 16 U.S. states and Washington D.C. we searched for 2019 state statutes and regulations related to MOUD in Westlaw legal database. We then identified laws that appeared designed to increase MOUD utilization and categorized them using a template analysis approach. Results: We found 82 laws with one or more MOUD expansion policies. We identified six high-level MOUD expansion policy categories: 1) policies expanding the availability of waivered buprenorphine providers; 2) needs assessments and policies increasing public MOUD awareness; 3) criminal justice system policies; 4) Substance use disorder (SUD) treatment and sober living facility policies; 5) insurance policies; and 6) hospital policies. SUD treatment and housing facility policies, as well as insurance policies, were most common. Conclusions: Multipronged approaches are being pursued by several states to increase MOUD access. Our results can inform policymakers of MOUD expansion approaches in other jurisdictions. Policy categories can serve as the basis for policy variables for future analyses of policy effects.
- Is Part Of:
- American journal of drug and alcohol abuse. Volume 48:Number 4(2022)
- Journal:
- American journal of drug and alcohol abuse
- Issue:
- Volume 48:Number 4(2022)
- Issue Display:
- Volume 48, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 48
- Issue:
- 4
- Issue Sort Value:
- 2022-0048-0004-0000
- Page Start:
- 492
- Page End:
- 503
- Publication Date:
- 2022-07-04
- Subjects:
- methadone -- buprenorphine -- state -- policy -- law -- opioid use disorder -- medications for opioid use disorder -- qualitative -- insurance -- criminal justice
Drug abuse -- Treatment -- Periodicals
Alcoholism -- Treatment -- Periodicals
Substance-abuse -- Treatment -- Periodicals
Alcoholism -- Periodicals
Substance-Related Disorders -- Periodicals
616.86 - Journal URLs:
- http://informahealthcare.com/loi/ada ↗
http://www.tandfonline.com/toc/iada20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/00952990.2022.2082301 ↗
- Languages:
- English
- ISSNs:
- 0095-2990
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0824.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23394.xml